These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 3358644)
41. Problems with tricyclic antidepressant use in patients with panic disorder or agoraphobia: results of a naturalistic follow-up study. Noyes R; Garvey MJ; Cook BL; Samuelson L J Clin Psychiatry; 1989 May; 50(5):163-9. PubMed ID: 2715139 [TBL] [Abstract][Full Text] [Related]
42. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder. Rizley R; Kahn RJ; McNair DM; Frankenthaler LM Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609 [No Abstract] [Full Text] [Related]
43. A naturalistic study of imipramine in panic disorder and agoraphobia. Aronson TA Am J Psychiatry; 1987 Aug; 144(8):1014-9. PubMed ID: 3300374 [TBL] [Abstract][Full Text] [Related]
44. A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients. Ravaris CL; Friedman MJ; Hauri PJ; McHugo GJ J Clin Psychopharmacol; 1991 Dec; 11(6):344-50. PubMed ID: 1770152 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of benzodiazepines in panic disorder and agoraphobia. Ballenger JC J Psychiatr Res; 1990; 24 Suppl 2():15-25. PubMed ID: 1980694 [TBL] [Abstract][Full Text] [Related]
46. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. Başoğlu M; Marks IM; Kiliç C; Swinson RP; Noshirvani H; Kuch K; O'Sullivan G Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder. Ciraulo DA; Barnhill JG; Boxenbaum HG; Greenblatt DJ; Smith RB J Clin Pharmacol; 1986 Apr; 26(4):292-8. PubMed ID: 2871050 [TBL] [Abstract][Full Text] [Related]
48. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment. Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302 [TBL] [Abstract][Full Text] [Related]
49. Three cases of panic disorder with agoraphobia in children. Ballenger JC; Carek DJ; Steele JJ; Cornish-McTighe D Am J Psychiatry; 1989 Jul; 146(7):922-4. PubMed ID: 2742019 [TBL] [Abstract][Full Text] [Related]
50. Reduction in hypochondriasis with treatment of panic disorder. Noyes R; Reich J; Clancy J; O'Gorman TW Br J Psychiatry; 1986 Nov; 149():631-5. PubMed ID: 3814956 [TBL] [Abstract][Full Text] [Related]
51. Alprazolam levels and response in panic disorder: preliminary results. Wincor MZ; Munjack DJ; Palmer R J Clin Psychopharmacol; 1991 Feb; 11(1):48-51. PubMed ID: 2040715 [TBL] [Abstract][Full Text] [Related]
52. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. Klein E; Colin V; Stolk J; Lenox RH Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882 [TBL] [Abstract][Full Text] [Related]
53. A case of alprazolam-related hepatitis. Judd FK; Norman TR; Marriott PF; Burrows GD Am J Psychiatry; 1986 Mar; 143(3):388-9. PubMed ID: 2869702 [No Abstract] [Full Text] [Related]
54. The structure of phobias in panic disorder. Argyle N; Solyom C; Solyom L Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949 [TBL] [Abstract][Full Text] [Related]
55. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder. Lopez AL; Kathol RG; Noyes R Psychoneuroendocrinology; 1990; 15(1):23-8. PubMed ID: 2367614 [TBL] [Abstract][Full Text] [Related]